Den samlede optagelse i knoglerne af QUADRAMET i studier med 453 patienter med forskellige former for primære maligniteter var 65, 5 ± 15, 5% af den indgivne radioaktivitet.
Total skeletal uptake of QUADRAMET in studies of 453 patients with a variety of primary malignancies was 65.5 ± 15.5% of the administered activity.